Ngenla Subcutaneous Injection Special Investigation

Clinical trial NCT05602766 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT05602766
Sponsor: Pfizer
Status: ACTIVE_NOT_RECRUITING
Study type: OBSERVATIONAL

Growth Hormone Deficiency Without Epiphyseal Closure

Start date: 2023-02-06
Primary completion: 2029-04-06
Enrollment: 1

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.